The Hypertension in the Very Elderly Trial (HYVET), a randomized trial with hip fracture as a secondary outcome measure, revealed that treatment with a thiazide-like diuretic ± ACE inhibitor may reduce the risk of hip fracture [31]. Here, ACE is linked to hypertensive disorder.